Blood Screening market size was USD 3.61 Billion in 2022!

Global Blood Screening market size was USD 3.61 Billion in 2022 and it is forecasted to reach USD 5.14 Billion by 2030. Blood Screening Industry's Compound Annual Growth Rate will be 8.5% from 2023 to 2030. Factors Affecting Blood Screening Market GrowthThe growing number of blood donationsIncreasing need for blood donation due to healthcare systems advancements and the need and availability of sophisticated surgical procedures including blood diseases, cardiovascular, therapy for cancer, transplant surgery, and trauma care. This is expected to drive the growth of the blood screening market. In addition, blood transfusions are generally prescribed in difficult childbearing to prepare for childhood inherited maternal blood disorders, trauma, and acute anemia. Furthermore, increasing blood safety from infectious diseases awareness through various programs. Rising accidents cases and prevalence of chronic diseases such as cancer. This is expected to drive the growth of the blood screening market in the forecast period. The Restraining Factor of Blood Screening:The high price of blood screening techniquesPreventing the blood screening expanding, despite rising rates of transfusion-transmissible illnesses and larger prevalence of HIV, hepatitis B, hepatitis C, and syphilis in developing nations like India, China, and Africa. The lack of funding for healthcare infrastructure in developing nations for blood screening procedures is the key factor restricting the growth of the blood screening market. In addition, high costs related to the test instruments and strict regulatory policies, are some of the factors anticipated to hamper the growth of the blood screening market in the forecast period. Impact of the COVID-19 Pandemic on the Blood Screening Market:During the COVID-19 pandemic, the blood screening market faced several difficulties including blood donations and collections were significantly decreased as a result of the lockdowns and limitations in the COVID-19 outbreak. In many nations, decreasing blood and blood components and negative effects on blood system operations. Additionally, the number of blood donors has been rising as the limitations are being loosened. The American Red Cross started analyzing all donated plasma, platelets, and blood samples for COVID-19 antibodies. Furthermore, during the pandemic, several companies quickly created a number of serological assays that quickly detect COVID-19 antibodies. Introduction of Blood ScreeningBlood screening is the process of analyzing a sample of blood to assess various aspects of an individual's health. It involves the examination of blood components, such as red and white blood cells, platelets, and plasma, and the detection of specific biomarkers, antibodies, hormones, or other substances present in the blood. In addition, the blood screening test is the blood chemistry panel which includes various tests that assess the levels of different chemicals and substances in the blood. Furthermore, this screening helps to monitor diseases and prevent health issues and a variety of other conditions such as infections and cancer. Blood donor screening is the defense mechanism implemented against the spread of infection prior to blood donation.

全球血液筛查市场规模于2022年达到361亿美元，预计到2030年将增长至514亿美元。血液筛查行业的复合年增长率将从2023年至2030年达到8.5%。影响血液筛查市场增长的因素包括血液捐赠数量的增加，以及由于医疗体系的进步和对复杂手术（包括血液疾病、心血管疾病、癌症治疗、移植手术和创伤护理）的需求与可获得性，导致对血液捐赠的需求增加。此外，血液输血通常在难产时被处方，以预防儿童遗传性母体血液疾病、创伤和急性贫血。此外，通过各种项目提高对传染性疾病的血液安全意识。事故案例的增加和慢性疾病（如癌症）的普遍存在，预计将在预测期内推动血液筛查市场的增长。血液筛查的制约因素包括血液筛查技术的昂贵价格，尽管输血传播疾病的发病率上升以及发展中国家（如印度、中国和非洲）HIV、乙型肝炎、丙型肝炎和梅毒的普遍率较高，但血液筛查的扩张受到限制。发展中国家医疗基础设施血液筛查程序的资金缺乏是限制血液筛查市场增长的关键因素。此外，与测试仪器相关的高成本和严格的监管政策，预计将阻碍预测期内血液筛查市场的增长。COVID-19大流行对血液筛查市场的影响：在COVID-19大流行期间，血液筛查市场面临了包括血液捐赠和收集显著减少在内的诸多困难，这是由于封锁和COVID-19疫情的限制所致。在许多国家，血液和血液成分的减少以及对血液系统运营的负面影响。此外，随着限制的放宽，献血者数量正在增加。美国红十字会开始对所有捐赠的血浆、血小板和血液样本进行COVID-19抗体分析。此外，在大流行期间，多家公司迅速开发出多种快速检测COVID-19抗体的血清学检测。血液筛查的引入：血液筛查是对血液样本进行分析的过程，以评估个体的健康各方面。它涉及对血液成分（如红细胞、白细胞、血小板和血浆）的检查，以及检测血液中存在的特定生物标志物、抗体、激素或其他物质。此外，血液筛查测试还包括血液生化分析，该分析包括各种测试，以评估血液中不同化学和物质的水平。此外，这种筛查有助于监测疾病和预防健康问题，以及感染和癌症等多种其他状况。血液捐赠者筛查是防止感染在血液捐赠前传播的防御机制。